Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04537403 · ClinicalTrials.gov registry record · Phase 1
PET Detection of CCR2 in Human Atherosclerosis
A Phase 1 study of Carotid Atherosclerosis, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04537403 is a Phase 1 study of Carotid Atherosclerosis that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 153-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04537403, a Phase 1 study of Carotid Atherosclerosis, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
Conditions Studied
Interventions
- DRUG Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
- DRUG Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)
Study Locations (1)
Missouri
- Washington University CCIR - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2025-09-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04537403
The ClinicalTrials.gov registry entry for NCT04537403 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (35% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carotid Atherosclerosis appearing as the primary indexed condition, and to 2 interventions - of which Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine) is the first listed.
NCT04537403 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04537403 about?
NCT04537403 is a clinical study titled "PET Detection of CCR2 in Human Atherosclerosis". : Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
What is the current status of trial NCT04537403?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2020-10-01. Estimated completion is 2025-09-01.
What conditions does trial NCT04537403 study?
This clinical trial studies the following conditions: Carotid Atherosclerosis.
What interventions are being tested in trial NCT04537403?
The interventions under investigation include: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine) (DRUG), Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine) (DRUG).
Who is sponsoring clinical trial NCT04537403?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04537403 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
COMPLETED · Phase 1
-
CANF-Comb-II PET-MR in Atherosclerosis Multisite
RECRUITING
-
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
ACTIVE NOT RECRUITING · Phase 4
-
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.